Canada's Competition Bureau investigates Cigna's Express Scripts for alleged anti-competitive practices like patient steering ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

Truist raised the firm’s price target on Cigna (CI) to $385 from $375 and keeps a Buy rating on the shares as part of a broader research note ...

Guggenheim kicked off coverage of Cigna with a Buy rating and a $384 target, praising its nimble healthcare strategy and reliable financial footing. The firm lauded Cigna’s flexible approach and low ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...

Chairman of the Federal Trade Commission Andrew Ferguson says he plans to resume a lawsuit alleging that the three leading ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The health sector is experiencing significant disruptions, with the FTC halting a lawsuit against pharmacy-benefit managers ...

The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his ...

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the ...